Bronstein, Gewirtz & Grossman, LLC Is Investigating Atara Biotherapeutics, Inc. (ATRA) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ:ATRA). Investors who purchased Atara securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/ATRA. […]

Edison International (EIX) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edison International ("Edison International") (NYSE:EIX) concerning possible violations of federal securities laws. On January 12, 2025, the Los Angeles Times published an article, "Officials investigating whether Southern California Edison equipment ignited Hurst

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 3, 2025 in Five9, Inc. Lawsuit – FIVN

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Five9, Inc. (NASDAQ:FIVN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/five9-inc-lawsuit-submission-form?prid=125460&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Levi & Korsinsky Reminds MGP Ingredients, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 14, 2025 – MGPI

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your MGP Ingredients, Inc. (NASDAQ:MGPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/mgp-ingredients-inc-lawsuit-submission-form?prid=125459&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Shareholders of Sun Communities, Inc. Should Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your Rights – SUI

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Sun Communities, Inc. (NYSE:SUI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sun-communities-inc-lawsuit-submission-form?prid=125458&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Levi & Korsinsky Notifies Pacira BioSciences, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – PCRX

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=125457&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Investors who lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class Action – BIOA

NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your BioAge Labs, Inc. (NASDAQ:BIOA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/bioage-labs-inc-lawsuit-submission-form?prid=125456&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

(NASDAQ:PCSA), HANOVER, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs with improved efficacy and safety, today announced the pricing of its “reasonable best efforts” public offering with participation from the Company's Chief Executive Officer,

Bright Green Corporation Has Signed Agreement with Majority Shareholder as Plan Sponsor on Prepackaged Plan to Restructure the Company.

(Other OTC:BGXX),(OTC US:BGXX), The Company plans to emerge with federal loan guarantees for its 60 new mega farm owner/operators, that collectively will invest $3.5 billion to supply and strengthen the Drugs Made in America supply Chain. FORT LAUDERDALE, FLORIDA, Jan. 27, 2025 (GLOBE NEWSWIRE) — Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”)

Class Action Announcement for Crocs, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against Crocs, Inc.

(NASDAQ:CROX), RADNOR, Pa., Jan. 27, 2025 (GLOBE NEWSWIRE) — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ: CROX) (“Crocs” or the “Company”) on behalf of investors who purchased or otherwise acquired Crocs common stock between November

Scroll to Top